Cargando…

Susceptibility-Weighted Imaging Provides Insight into White Matter Damage in Amyotrophic Lateral Sclerosis

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a fatal, progressive neurodegenerative disorder, characterised by widespread white matter damage. There is growing evidence that disturbances in iron metabolism contribute to white matter alterations. MATERIALS & METHODS: We analysed the data of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prell, Tino, Hartung, Viktor, Tietz, Florian, Penzlin, Susanne, Ilse, Benjamin, Schweser, Ferdinand, Deistung, Andreas, Bokemeyer, Martin, Reichenbach, Jürgen R., Witte, Otto W., Grosskreutz, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481412/ https://www.ncbi.nlm.nih.gov/pubmed/26110427 http://dx.doi.org/10.1371/journal.pone.0131114

Ejemplares similares

Voxel-Based MRI Intensitometry Reveals Extent of Cerebral White Matter Pathology in Amyotrophic Lateral Sclerosis
por: Hartung, Viktor, et al.
Publicado: (2014)

Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis
por: Keil, Carsten, et al.
Publicado: (2012)

Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis
por: Prell, Tino, et al.
Publicado: (2019)

Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2021)

Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model
por: Steinbach, Robert, et al.
Publicado: (2020)

Use of vitamins by participants in amyotrophic lateral sclerosis clinical trials
por: Prell, Tino, et al.
Publicado: (2020)

Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model
por: Steinbach, Robert, et al.
Publicado: (2020)

Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2019)

Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data
por: Prell, Tino, et al.
Publicado: (2020)

Monocyte-Derived Macrophages Contribute to Chitinase Dysregulation in Amyotrophic Lateral Sclerosis: A Pilot Study
por: Gaur, Nayana, et al.
Publicado: (2021)

Reaction to Endoplasmic Reticulum Stress via ATF6 in Amyotrophic Lateral Sclerosis Deteriorates With Aging
por: Prell, Tino, et al.
Publicado: (2019)

Blood–Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis
por: Prell, Tino, et al.
Publicado: (2021)

The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis
por: Tadic, Vedrana, et al.
Publicado: (2014)

Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?
por: Prell, Tino, et al.
Publicado: (2016)

Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness
por: Dieckmann, Nora, et al.
Publicado: (2022)

The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond
por: Gaur, Nayana, et al.
Publicado: (2020)

Amyotrophic Lateral Sclerosis: Advances and Prospects
por: Boentert, Matthias, et al.
Publicado: (2023)

Developing a Neuroimaging Biomarker for Amyotrophic Lateral Sclerosis: Multi-Center Data Sharing and the Road to a “Global Cohort”
por: Steinbach, Robert, et al.
Publicado: (2018)

Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
por: Menke, Ricarda A. L., et al.
Publicado: (2016)

Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
por: Dreger, Marie, et al.
Publicado: (2022)

DNA plasticity and damage in amyotrophic lateral sclerosis
por: Penndorf, Diane, et al.
Publicado: (2018)

Changes of deep gray matter magnetic susceptibility over 2 years in multiple sclerosis and healthy control brain
por: Hagemeier, Jesper, et al.
Publicado: (2017)

DNA strand breaks and TDP-43 mislocation are absent in the murine hSOD1(G93A) model of amyotrophic lateral sclerosis in vivo and in vitro
por: Penndorf, Diane, et al.
Publicado: (2017)

Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease
por: Prell, Tino, et al.
Publicado: (2019)

High-Resolution MR Imaging of the Human Brainstem In vivo at 7 Tesla
por: Deistung, Andreas, et al.
Publicado: (2013)

Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model
por: Dreger, Marie, et al.
Publicado: (2021)

Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis
por: Grosskreutz, Julian, et al.
Publicado: (2006)

Magnetic susceptibility anisotropy in normal appearing white matter in multiple sclerosis from single-orientation acquisition
por: Sibgatulin, Renat, et al.
Publicado: (2022)

Classification of amyotrophic lateral sclerosis by brain volume, connectivity, and network dynamics
por: Thome, Janine, et al.
Publicado: (2021)

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
por: Kuraszkiewicz, B., et al.
Publicado: (2020)

Implications of white matter damage in amyotrophic lateral sclerosis
por: Zhou, Ting, et al.
Publicado: (2017)

Evolution of white matter damage in amyotrophic lateral sclerosis
por: Gabel, Matt C., et al.
Publicado: (2020)

Association between malnutrition, clinical parameters and health-related quality of life in elderly hospitalized patients with Parkinson’s disease: A cross-sectional study
por: Gruber, Maria Theresa, et al.
Publicado: (2020)

Multimodal assessment of white matter tracts in amyotrophic lateral sclerosis
por: Borsodi, Florian, et al.
Publicado: (2017)

Fiber-specific white matter reductions in amyotrophic lateral sclerosis
por: Cheng, Luqi, et al.
Publicado: (2020)

Extent of cortical involvement in amyotrophic lateral sclerosis – an analysis based on cortical thickness
por: Thorns, Johannes, et al.
Publicado: (2013)

Data on adherence to medication in neurological patients using the German Stendal Adherence to Medication Score (SAMS)
por: Prell, Tino, et al.
Publicado: (2019)

Sicca Symptoms in Parkinson's Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life
por: Prell, Tino, et al.
Publicado: (2020)

Trends in the diagnostic delay and pathway for amyotrophic lateral sclerosis patients across different countries
por: Falcão de Campos, Catarina, et al.
Publicado: (2023)

Subtle retinal pathology in amyotrophic lateral sclerosis
por: Ringelstein, Marius, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_masbg8k9thir3s7tn8qdshnecg